213 related articles for article (PubMed ID: 32764971)
1. The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors.
Chen R; Chen Y; Zhao W; Fang C; Zhou W; Yang X; Ji M
Onco Targets Ther; 2020; 13():6837-6846. PubMed ID: 32764971
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
Han X; Piao L; Yuan X; Wang L; Liu Z; He X
Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
[No Abstract] [Full Text] [Related]
3. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
[TBL] [Abstract][Full Text] [Related]
4. NSD2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression.
Lu MH; Fan MF; Yu XD
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):928-936. PubMed ID: 28338204
[TBL] [Abstract][Full Text] [Related]
5. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
6. Cancers and the NSD family of histone lysine methyltransferases.
Morishita M; di Luccio E
Biochim Biophys Acta; 2011 Dec; 1816(2):158-63. PubMed ID: 21664949
[TBL] [Abstract][Full Text] [Related]
7. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1.
Zhang J; Xie W; Ni B; Li Z; Feng D; Zhang Y; Han Q; Zhou H; Gu M; Tan R
Pharmacol Res; 2024 Feb; 200():107051. PubMed ID: 38190956
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.
Gao B; Liu X; Li Z; Zhao L; Pan Y
Front Oncol; 2020; 10():600514. PubMed ID: 33665162
[TBL] [Abstract][Full Text] [Related]
9. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
Zhu L; Yu CL; Zheng Y
Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.
di Luccio E
J Cancer Prev; 2015 Jun; 20(2):113-20. PubMed ID: 26151044
[TBL] [Abstract][Full Text] [Related]
11. NSD2 as a Promising Target in Hematological Disorders.
Azagra A; Cobaleda C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
[TBL] [Abstract][Full Text] [Related]
12. NMR backbone resonance assignment and solution secondary structure determination of human NSD1 and NSD2.
Amin N; Nietlispach D; Qamar S; Coyle J; Chiarparin E; Williams G
Biomol NMR Assign; 2016 Oct; 10(2):315-20. PubMed ID: 27356987
[TBL] [Abstract][Full Text] [Related]
13. NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling.
Han X; Piao L; Xu X; Luo F; Liu Z; He X
Cancer Manag Res; 2020; 12():375-383. PubMed ID: 32021450
[TBL] [Abstract][Full Text] [Related]
14. Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers.
Chen R; Zhao WQ; Fang C; Yang X; Ji M
J Cancer; 2020; 11(11):3349-3356. PubMed ID: 32231741
[TBL] [Abstract][Full Text] [Related]
15. Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression.
Li M; Chen H; Yang X; Zhang W; Ma C; Wang Q; Wang X; Gao R
Animal Model Exp Med; 2024 Feb; ():. PubMed ID: 38400589
[TBL] [Abstract][Full Text] [Related]
16. NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.
Zhou XL; Zhu RR; Wu X; Xu H; Li YY; Xu QR; Liu S; Huang H; Xu X; Wan L; Wu QC; Liu JC
J Cell Mol Med; 2019 Jan; 23(1):568-575. PubMed ID: 30334333
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives.
Zhang L; Zha X
Eur J Med Chem; 2023 Mar; 250():115232. PubMed ID: 36863225
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.
He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
[TBL] [Abstract][Full Text] [Related]
19. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
Morishita M; Mevius D; di Luccio E
BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
[TBL] [Abstract][Full Text] [Related]
20. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
